- Home
- RYTM vs MKTX Comparison
RYTM vs MKTX Comparison
Compare RYTM & MKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- MKTX
- Stock Information
- Founded
- RYTM 2008
- MKTX 2000
- Country
- RYTM United States
- MKTX United States
- Employees
- RYTM N/A
- MKTX N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- MKTX Investment Bankers/Brokers/Service
- Sector
- RYTM Health Care
- MKTX Finance
- Exchange
- RYTM Nasdaq
- MKTX Nasdaq
- Market Cap
- RYTM 6.4B
- MKTX 6.7B
- IPO Year
- RYTM 2017
- MKTX 2004
- Fundamental
- Price
- RYTM $97.86
- MKTX $167.88
- Analyst Decision
- RYTM Strong Buy
- MKTX Buy
- Analyst Count
- RYTM 13
- MKTX 11
- Target Price
- RYTM $109.77
- MKTX $226.18
- AVG Volume (30 Days)
- RYTM 627.7K
- MKTX 1.2M
- Earning Date
- RYTM 11-04-2025
- MKTX 11-05-2025
- Dividend Yield
- RYTM N/A
- MKTX 1.81%
- EPS Growth
- RYTM N/A
- MKTX N/A
- EPS
- RYTM N/A
- MKTX 5.95
- Revenue
- RYTM $156,287,000.00
- MKTX $837,157,000.00
- Revenue This Year
- RYTM $46.10
- MKTX $6.89
- Revenue Next Year
- RYTM $60.39
- MKTX $8.86
- P/E Ratio
- RYTM N/A
- MKTX $28.20
- Revenue Growth
- RYTM 53.55
- MKTX 7.67
- 52 Week Low
- RYTM $45.91
- MKTX $161.61
- 52 Week High
- RYTM $106.52
- MKTX $296.68
- Technical
- Relative Strength Index (RSI)
- RYTM 49.11
- MKTX 27.99
- Support Level
- RYTM $95.88
- MKTX $168.74
- Resistance Level
- RYTM $102.79
- MKTX $171.98
- Average True Range (ATR)
- RYTM 3.20
- MKTX 3.85
- MACD
- RYTM -0.25
- MKTX -0.72
- Stochastic Oscillator
- RYTM 32.99
- MKTX 26.51
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.